14M109: Polymyalgia Rheumatica: New Tricks for an Old Disease

Monday, November 14, 2022

9:00 AM – 10:00 AM Eastern Time

Location: Room 201

CE: 1

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

MP

Mike Putman, MD, MSc

The Medical College of Wisconsin
Milwaukee, WI, United States

Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing)
Sebastian Sattui, MD, MS

University of Pittsburgh
Pittsburgh, PA, United States

Disclosure(s): AstraZeneca: Grant/Research Support (Ongoing)

Polymyalgia rheumatica (PMR) is one of the most common systemic rheumatic diseases of the elderly. Despite its high prevalence among rheumatic diseases, there are still several unmet needs and gaps in our knowledge of PMR, particularly with regards to treatment (e.g. optimal duration of steroids and use of steroid-sparing agents) and disease activity monitoring.

Recently, advances in our understanding of pathophysiology and studies of possible new therapeutics show some promise. Advances in imaging may inform the diagnosis and monitoring of PMR. This symposium will provide an update on PMR diagnosis, monitoring, and treatment. The session will highlight important items in the research agenda and the potential implementation in upcoming clinical trials in PMR.

Learning Objectives:

Describe the current treatment approach for PMR
Recognize new steroid-sparing agents currently being studied for the treatment of PMR and the rationale behind them.
Explain advances in imaging modalities for diagnosing and monitoring PMR

Presentations:

9:00 AM – 9:20 AM Eastern Time

Advances in PMR Imaging: Diagnosis and Disease Monitoring
Speaker: Claire E. Owen, PhD, FRACP – Austin Health
9:20 AM – 9:40 AM Eastern Time

Balancing Risks and Benefits of Adding Immunosuppression to Steroids in PMR
Speaker: Christian Dejaco, MD – Azienda Sanitaria Alto Adige
9:40 AM – 10:00 AM Eastern Time

Q&A